Combining drug-eluting bead chemoembolization and radioembolization for treatment of colorectal liver metastases: DEBIR90Y study
NL66938.041.19
Phase 1 other active
Quick answer
Combining drug-eluting bead chemoembolization and radioembolization for treatment of colorectal liver metastases: DEBIR90Y study for colorectal liver metastases is a Phase 1 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- colorectal liver metastases
- Phase
- Phase 1
- Modality
- other
- Status
- active